Seagull BioSolutions: A Pioneer in Biotechnology for Healthcare

Seagull BioSolutions is a company that develops innovative biological technologies for producing new and affordable healthcare products, such as vaccines, therapeutics, and gene therapy agents. Seagull BioSolutions is based in Pune, India, and has a team of highly qualified and experienced scientists who work on cutting-edge research and development. Seagull BioSolutions has developed a proprietary mammalian expression system, called the eSAME technology, that is versatile, efficient, and scalable. Seagull BioSolutions is using this technology platform to create novel healthcare products that address important unmet medical needs.

Seagull BioSolutions

Details of the startup:

  • CITY : Pune
  • STATE : Maharashtra
  • STARTED IN : 2011
  • FOUNDERS : Manisha Premnath, Shruti Vishwas Joshi and Vishwas D. Joshi.
  • NUMBER OF INVESTORS : 5
  • LATEST ROUND INVESTMENT : ₹25.00M
  • TOTAL INVESTMENT : ₹34.22M
  •   TOTAL SECURED LOANS AVAILED : Nil

You can find their website here.

REVY Environmental Solutions: A Biotechnology Firm That Transforms Waste into Resources

What is Seagull BioSolutions?

Seagull BioSolutions is a company that was started in 2011 with a desire to develop innovative biological technologies for healthcare applications. Seagull BioSolutions is an RBI registered app that partners with NBFCs to offer loans ranging from Rs. 500 to Rs. 10,000, with a tenure of 3 months, and an interest rate of 24%-36% p.a.

Seagull BioSolutions has a vision to become a global leader in biotechnology for healthcare, and a mission to provide affordable and accessible healthcare products to the masses. Seagull BioSolutions has a core value of excellence, innovation, and social responsibility, and strives to create a positive impact on the society and the environment.

Seagull BioSolutions has a state-of-the-art research and development facility located in the NCL Innovation Park, Pune, where it is a resident incubatee of Venture Center. Seagull BioSolutions also has close collaborations with leading research institutes and organizations, such as the National Chemical Laboratory, National Institute of Virology, Indian Institute of Scientific and Educational Research, National Center for Cell Sciences, and Agarkar Research Institute.

Seagull BioSolutions has a team of nationally and internationally trained scientists, who have expertise in various fields of biotechnology, such as molecular biology, immunology, virology, cell biology, and bioinformatics. Seagull BioSolutions also has a board of directors and a scientific advisory board, who provide guidance and support to the company’s vision and strategy.

Bharat Biotech: The Indian Biotechnology Company that is Making a Global Impact

What is the eSAME technology?

The eSAME technology is a proprietary mammalian expression system that Seagull BioSolutions has developed for producing recombinant proteins, viral vaccines, therapeutic and gene therapy agents. The eSAME technology stands for “expression System for Adenovirus Mediated Expression”, and is based on the use of a modified adenovirus vector that can deliver and express any gene of interest in mammalian cells.

The eSAME technology has several advantages over conventional expression systems, such as:

  • Versatility: The eSAME technology can be used to produce a wide range of healthcare products, such as vaccines, antibodies, enzymes, hormones, cytokines, and gene therapy agents.
  • Efficiency: The eSAME technology can achieve high levels of gene expression and protein production in mammalian cells, without affecting their viability and functionality.
  • Scalability: The eSAME technology can be easily scaled up for large-scale production of healthcare products, using bioreactors and cell culture systems.
  • Safety: The eSAME technology uses a modified adenovirus vector that is non-replicative and non-integrative, and thus does not pose any risk of viral infection or genomic integration.
Pandorum Technologies: Building Blocks of Life

What are the products of Seagull BioSolutions?

Seagull BioSolutions is using the eSAME technology to develop novel healthcare products that address important unmet medical needs. Some of the products that Seagull BioSolutions is working on are:

  • COVID-19 vaccine: Seagull BioSolutions is developing a COVID-19 vaccine that is based on the eSAME technology and the spike protein of the SARS-CoV-2 virus. The vaccine is expected to induce a strong and durable immune response against the virus, and provide protection against the variants. The vaccine is currently in the preclinical stage of development, and is expected to enter the clinical trials soon.
  • Dengue vaccine: Seagull BioSolutions is developing a dengue vaccine that is based on the eSAME technology and the envelope protein of the four serotypes of the dengue virus. The vaccine is expected to induce a balanced and protective immune response against all the serotypes, and prevent the severe complications of dengue, such as dengue hemorrhagic fever and dengue shock syndrome. The vaccine is currently in the preclinical stage of development, and is expected to enter the clinical trials soon.
  • Cancer therapeutics: Seagull BioSolutions is developing cancer therapeutics that are based on the eSAME technology and the oncolytic adenovirus. The therapeutics are expected to selectively infect and kill the cancer cells, and stimulate the immune system to eliminate the tumor. The therapeutics are currently in the preclinical stage of development, and are expected to enter the clinical trials soon.
  • Gene therapy agents: Seagull BioSolutions is developing gene therapy agents that are based on the eSAME technology and the therapeutic genes. The gene therapy agents are expected to deliver and express the therapeutic genes in the target cells, and correct the genetic defects or diseases. The gene therapy agents are currently in the preclinical stage of development, and are expected to enter the clinical trials soon.
URAVU LABS: Breathing Life into the Arid Lands with Air-to-Water Technology

Seagull BioSolutions is a company that develops innovative biological technologies for healthcare applications. Seagull BioSolutions has developed a proprietary mammalian expression system, called the eSAME technology, that is versatile, efficient, and scalable. Seagull BioSolutions is using this technology platform to create novel healthcare products that address important unmet medical needs, such as COVID-19, dengue, cancer, and gene therapy. Seagull BioSolutions is a pioneer in biotechnology for healthcare, and aims to provide affordable and accessible healthcare products to the masses.

Follow : LinkedIn

 

You May Also Like

More From Author

+ There are no comments

Add yours